Decreased serum and red blood cell kynurenic acid levels in Alzheimer's disease

Research output: Article

77 Citations (Scopus)

Abstract

Kynurenine aminotransferases (KAT I and KAT II) are responsible for the transamination of kynurenine (KYN) to form kynurenic acid (KYNA), an excitatory amino acid receptor antagonist. Since these members of the kynurenine pathway (KP) are proposed to be involved in the pathogenesis of Alzheimer's dementia (AD), the activities of these enzymes and the levels of these metabolites were measured in the plasma and red blood cells (RBCs) of AD and control subjects together with the inheritance of the apolipoprotein (APOE) ε4 allele. KYNA levels were significantly decreased both in the plasma and in the RBCs in AD, but the levels of KYN and the activities of KAT I and KAT II remained unchanged. No association has been found with the possession of the ε4 allele. These findings indicate an altered peripheral KP in AD regardless of the APOE status of the probands.

Original languageEnglish
Pages (from-to)308-313
Number of pages6
JournalNeurochemistry international
Volume50
Issue number2
DOIs
Publication statusPublished - jan. 1 2007

    Fingerprint

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Cell Biology

Cite this